Rekombinante Hepatitis-B-Impfstoffe und Verdachtsfälle unerwünschter Reaktionen Eine Bewertung der Spontanerfassungsdaten des Paul-Ehrlich-Instituts 1995 bis 2000: Eine Bewertung der Spontanerfassungsdaten des Paul-Ehrlich-Instituts 1995 bis 2000

In October 1995, after realising that the strategy of immunising only individuals at high risk for hepatitis B infections did not influence the incidence, the STIKO (permanent Committee on Vaccination at the Robert Koch-Institute) recommended the general immunisation of all infants and children. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Hartmann, K., Keller-Stanislawski, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2014
Materias:
Originalien und Übersichtsarbeiten
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095933/
https://www.ncbi.nlm.nih.gov/pubmed/24676980
http://dx.doi.org/10.1007/s00103-002-0388-1
Descripción
Sumario:In October 1995, after realising that the strategy of immunising only individuals at high risk for hepatitis B infections did not influence the incidence, the STIKO (permanent Committee on Vaccination at the Robert Koch-Institute) recommended the general immunisation of all infants and children. The number of paediatric doses of recombinant vaccine sold between1995 and 2000 shows that HBV vaccination is widely accepted by paediatricians. The cases of suspected adverse reactions reported from the German spontaneous pharmacovigilance system are summarised and discussed.

Ejemplares similares